Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA   US9216591084

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/21/2014 11/24/2014 11/25/2014 11/26/2014 11/28/2014 Date
12.58(c) 12.99(c) 12.69(c) 12.89(c) 13.03(c) Last
697 427 660 677 593 964 558 794 405 299 Volume
+4.92% +3.26% -2.31% +1.58% +1.09% Change
More quotes
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its product portfolio includes Fanapt and Tasimelteon.The Fanapt product is a compound for the treatment of schizophrenia, the... 
Surperformance© rating of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More about the company
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 51,2 M
EBIT 2014 -57,4 M
Net income 2014 -57,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 90,6 M
EBIT 2015 -26,2 M
Net income 2015 -41,5 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 9,98x
Capi. / Sales 2015 5,64x
Capitalization 511 M
More Financials
Latest news on VANDA PHARMACEUTICALS INC.
3d ago VANDA PHARMACEUTICALS : to Present at the Stifel Nicolaus 2014 Healthcare Confer..
11/18 VANDA PHARMACEUTICALS : to Present at the Stifel Nicolaus 2014 Healthcare Confer..
11/03 VANDA PHARMACEUTICALS : Other Events (form 8-K)
10/31 VANDA PHARMACEUTICALS : U.S. Patents Awarded to Inventors in Kansas (Oct. 31)
10/31 VANDA PHARMACEUTICALS : Assigned Patent
10/31 VANDA PHARMACEUTICALS : Assigned Patent
10/31 VANDA PHARMACEUTICALS : to Sell Stock
10/29 VANDA PHARMACEUTICALS : Patent Issued for Stable Dosage Formulations of Imidazol..
10/29 VANDA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Amendments t..
10/29 VANDA PHARMACEUTICALS : Prices Public Offering of Common Stock
10/28 VANDA PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
10/28 VANDA PHARMACEUTICALS : Proposes Public Offering of Common Stock
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF